HK1258053A1 - 作為蛋白激酶抑制劑的新的2，3，5-取代的噻吩化合物 - Google Patents
作為蛋白激酶抑制劑的新的2，3，5-取代的噻吩化合物Info
- Publication number
- HK1258053A1 HK1258053A1 HK19100430.7A HK19100430A HK1258053A1 HK 1258053 A1 HK1258053 A1 HK 1258053A1 HK 19100430 A HK19100430 A HK 19100430A HK 1258053 A1 HK1258053 A1 HK 1258053A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- novel
- protein kinase
- kinase inhibitor
- substituted thiophene
- thiophene compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
- C07D333/10—Thiophene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160017991 | 2016-02-16 | ||
| PCT/KR2017/001715 WO2017142325A1 (ko) | 2016-02-16 | 2017-02-16 | 단백질 키나아제 저해제인 신규 2,3,5-치환된 싸이오펜 화합물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1258053A1 true HK1258053A1 (zh) | 2019-11-01 |
Family
ID=59626142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK19100430.7A HK1258053A1 (zh) | 2016-02-16 | 2019-01-11 | 作為蛋白激酶抑制劑的新的2，3，5-取代的噻吩化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10442796B2 (zh) |
| EP (1) | EP3418275B1 (zh) |
| JP (2) | JP6749422B2 (zh) |
| KR (3) | KR20170096599A (zh) |
| CN (1) | CN108884066B (zh) |
| AU (1) | AU2017221707B2 (zh) |
| BR (1) | BR112018016729B1 (zh) |
| CA (1) | CA3014740C (zh) |
| DK (1) | DK3418275T3 (zh) |
| ES (1) | ES2866890T3 (zh) |
| HK (1) | HK1258053A1 (zh) |
| MX (1) | MX383812B (zh) |
| NZ (1) | NZ745210A (zh) |
| PT (1) | PT3418275T (zh) |
| RU (1) | RU2724957C2 (zh) |
| WO (1) | WO2017142325A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX383812B (es) * | 2016-02-16 | 2025-03-14 | Korea Inst Sci & Tech | Compuesto novedoso de tiofeno 2,3,5-sustituido como inhibidor de la proteina cinasa. |
| WO2019231220A1 (ko) * | 2018-05-30 | 2019-12-05 | (주)파로스아이비티 | 2,3,5-치환된 싸이오펜 화합물의 유방암 예방, 개선 또는 치료 용도 |
| US20210205289A1 (en) * | 2018-05-30 | 2021-07-08 | Pharos Ibio Co., Ltd. | Use of 2,3,5-substituted thiophene compound for enhancement of radiotherapy |
| TWI727392B (zh) | 2018-08-13 | 2021-05-11 | 美商基利科學股份有限公司 | 噻二唑irak4抑制劑 |
| CN110643672A (zh) * | 2019-10-15 | 2020-01-03 | 西安交通大学 | 高表达TrkB作为新型靶点在抑制胰腺癌转移方面的医药用途 |
| KR102578970B1 (ko) * | 2020-03-04 | 2023-09-15 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 난소암 예방, 개선 또는 치료 용도 |
| JP7407298B2 (ja) * | 2020-03-04 | 2023-12-28 | ファロス・アイバイオ・カンパニー・リミテッド | ２，３，５－置換されたチオフェン化合物の卵巣癌の予防、改善または治療用途 |
| KR102535842B1 (ko) * | 2020-07-31 | 2023-05-23 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 비만세포증 예방, 개선 또는 치료 용도 |
| KR102535840B1 (ko) * | 2020-07-31 | 2023-05-23 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 위장관기질종양 예방, 개선 또는 치료 용도 |
| WO2023063784A1 (ko) * | 2021-10-14 | 2023-04-20 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물을 포함하는 병용 투여용 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU691820B2 (en) | 1993-07-15 | 1998-05-28 | Cancer Research Campaign Technology Limited | Prodrugs of protein tyrosine kinase inhibitors |
| US6414013B1 (en) * | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| CA2504320A1 (en) * | 2002-10-30 | 2004-05-21 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
| JP2005064770A (ja) * | 2003-08-11 | 2005-03-10 | Ricoh Co Ltd | 情報処理装置、認証装置、外部装置、証明情報取得方法、認証方法、機能提供方法、証明情報取得プログラム、認証プログラム、機能提供プログラム及び記録媒体 |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| JP2007517843A (ja) * | 2004-01-05 | 2007-07-05 | アストラゼネカ アクチボラグ | Ｃｈｋ１阻害剤であるチオフェン誘導体 |
| RU2006138036A (ru) * | 2004-03-30 | 2008-05-10 | Чирон Корпорейшн (Us) | Производные замещенного тиофена в качестве противораковых средств |
| JP2008534565A (ja) * | 2005-03-31 | 2008-08-28 | アストラゼネカ アクチボラグ | Ｔｉｅ２阻害活性のあるアミノピリミジン誘導体 |
| KR100703622B1 (ko) * | 2005-10-26 | 2007-04-06 | 삼성전기주식회사 | 캡 방식의 카메라 모듈 |
| JP5581219B2 (ja) * | 2008-01-25 | 2014-08-27 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用 |
| BR112013018212B1 (pt) * | 2011-01-21 | 2021-12-14 | Sun Pharma Advanced Research Company Ltd | Inibidores de tirosino quinase contendo diarilacettleno hidrazida |
| MX383812B (es) * | 2016-02-16 | 2025-03-14 | Korea Inst Sci & Tech | Compuesto novedoso de tiofeno 2,3,5-sustituido como inhibidor de la proteina cinasa. |
-
2017
- 2017-02-16 MX MX2018009861A patent/MX383812B/es unknown
- 2017-02-16 KR KR1020170020896A patent/KR20170096599A/ko not_active Ceased
- 2017-02-16 BR BR112018016729-0A patent/BR112018016729B1/pt active IP Right Grant
- 2017-02-16 CA CA3014740A patent/CA3014740C/en active Active
- 2017-02-16 JP JP2018561463A patent/JP6749422B2/ja active Active
- 2017-02-16 CN CN201780021441.1A patent/CN108884066B/zh active Active
- 2017-02-16 ES ES17753486T patent/ES2866890T3/es active Active
- 2017-02-16 AU AU2017221707A patent/AU2017221707B2/en active Active
- 2017-02-16 NZ NZ745210A patent/NZ745210A/en unknown
- 2017-02-16 RU RU2018130703A patent/RU2724957C2/ru active
- 2017-02-16 DK DK17753486.4T patent/DK3418275T3/da active
- 2017-02-16 PT PT177534864T patent/PT3418275T/pt unknown
- 2017-02-16 EP EP17753486.4A patent/EP3418275B1/en active Active
- 2017-02-16 WO PCT/KR2017/001715 patent/WO2017142325A1/ko active Application Filing
-
2018
- 2018-08-16 US US15/998,791 patent/US10442796B2/en active Active
- 2018-12-17 KR KR1020180163545A patent/KR101965326B1/ko active Active
-
2019
- 2019-01-11 HK HK19100430.7A patent/HK1258053A1/zh unknown
- 2019-03-27 KR KR1020190035405A patent/KR102069730B1/ko active Active
-
2020
- 2020-05-20 JP JP2020088146A patent/JP2020143118A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020143118A (ja) | 2020-09-10 |
| KR20170096599A (ko) | 2017-08-24 |
| CA3014740C (en) | 2021-06-01 |
| BR112018016729B1 (pt) | 2023-10-24 |
| KR20180136425A (ko) | 2018-12-24 |
| MX2018009861A (es) | 2019-06-06 |
| EP3418275B1 (en) | 2021-03-17 |
| KR20190035671A (ko) | 2019-04-03 |
| BR112018016729A2 (pt) | 2018-12-26 |
| ES2866890T3 (es) | 2021-10-20 |
| CN108884066B (zh) | 2021-08-24 |
| KR102069730B1 (ko) | 2020-01-23 |
| PT3418275T (pt) | 2021-04-22 |
| US20190047993A1 (en) | 2019-02-14 |
| JP2019504900A (ja) | 2019-02-21 |
| MX383812B (es) | 2025-03-14 |
| EP3418275A1 (en) | 2018-12-26 |
| WO2017142325A1 (ko) | 2017-08-24 |
| AU2017221707A1 (en) | 2018-08-30 |
| KR101965326B1 (ko) | 2019-04-03 |
| NZ745210A (en) | 2019-08-30 |
| RU2018130703A (ru) | 2020-03-17 |
| AU2017221707B2 (en) | 2019-10-03 |
| EP3418275A4 (en) | 2019-07-17 |
| CA3014740A1 (en) | 2017-08-24 |
| JP6749422B2 (ja) | 2020-09-02 |
| DK3418275T3 (da) | 2021-05-10 |
| RU2018130703A3 (zh) | 2020-03-17 |
| RU2724957C2 (ru) | 2020-06-29 |
| CN108884066A (zh) | 2018-11-23 |
| US10442796B2 (en) | 2019-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258053A1 (zh) | 作為蛋白激酶抑制劑的新的2，3，5-取代的噻吩化合物 | |
| SG11202104326TA (en) | 2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors | |
| IL256898B (en) | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | |
| LT3577110T (lt) | 8-oksetan-3-il-3,8-diazabiciklo[3.2.1]oktan-3-ilo pakeistieji junginiai, kaip živ inhibitoriai | |
| LT3580220T (lt) | Aminotriazolopiridinai, kaip kinazės inhibitoriai | |
| IL276269A (en) | Aminopyrrolotriazines as kinase inhibitors | |
| IL267899A (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors | |
| LT3704118T (lt) | Aminoimidazopiridazinai, kaip kinazės inhibitoriai | |
| IL271104B (en) | Heteroaromatic compounds as vanin inhibitors | |
| ZA201701131B (en) | Novel 2,5-substituted pyrimidines as pde4 inhibitors | |
| IL283397A (en) | Heteroaromatic compounds as vanin inhibitors | |
| IL280898A (en) | Heteroaromatic compounds as vanin inhibitors | |
| EP3666770A4 (en) | NEW HETEROCYCLIC COMPOUNDS AS CDK8 / 19 INHIBITORS | |
| ZA202000107B (en) | Aminothiazole compounds as protein kinase inhibitors | |
| ZA201701132B (en) | Novel 2,5-substituted pyrimidines as pde inhibitors | |
| PT3643718T (pt) | Composto heterocíclico e seu uso como modulador alostérico positivo do recetor muscarínico colinérgico m1 | |
| HK1256825A1 (zh) | 取代的5，6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式 | |
| EP3660003C0 (en) | HETEROCYCLIC COMPOUND | |
| EP2982378A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE | |
| IL252986A0 (en) | 5,3-diaminopyrazole kinase inhibitors | |
| IL265578A (en) | 5-substituted imidazolylmethyldioxolane derivatives as fungicides | |
| SG11202003286YA (en) | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative | |
| PL3891142T3 (pl) | Związki heteroaromatyczne jako inhibitory waniny | |
| ZA201908372B (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| ZA201907792B (en) | Heterocyclic compound |